Bass A - Search Results

1

Non-clinical evaluation of ventricular repolarization (ICH S7B): results of an interim survey of international pharmaceutical companies.

Friedrichs GS, Patmore L, Bass A. Friedrichs GS, et al. Among authors: bass a. J Pharmacol Toxicol Methods. 2005 Jul-Aug;52(1):6-11. doi: 10.1016/j.vascn.2005.05.001. J Pharmacol Toxicol Methods. 2005. PMID: 15975833 Review.

2

Benchmarking safety pharmacology regulatory packages and best practice.

Lindgren S, Bass AS, Briscoe R, Bruse K, Friedrichs GS, Kallman MJ, Markgraf C, Patmore L, Pugsley MK. Lindgren S, et al. J Pharmacol Toxicol Methods. 2008 Sep-Oct;58(2):99-109. doi: 10.1016/j.vascn.2008.07.001. Epub 2008 Jul 19. J Pharmacol Toxicol Methods. 2008. PMID: 18692579

3

The cardiovascular and pharmacokinetic profile of dofetilide in conscious telemetered beagle dogs and cynomolgus monkeys.

Haushalter TM, Friedrichs GS, Reynolds DL, Barecki-Roach M, Pastino G, Hayes R, Bass AS. Haushalter TM, et al. Among authors: bass as. Br J Pharmacol. 2008 Aug;154(7):1457-64. doi: 10.1038/bjp.2008.275. Epub 2008 Jul 7. Br J Pharmacol. 2008. PMID: 18604237 Free PMC article.

4

Drugs effects on ventricular repolarization: a critical evaluation of the strengths and weaknesses of current methodologies and regulatory practices.

Bass AS, Tomaselli G, Bullingham R 3rd, Kinter LB. Bass AS, et al. J Pharmacol Toxicol Methods. 2005 Jul-Aug;52(1):12-21. doi: 10.1016/j.vascn.2005.04.010. J Pharmacol Toxicol Methods. 2005. PMID: 15967683 Review.

5

Points to consider emerging from a mini-workshop on cardiac safety: assessing torsades de pointes liability.

Bass A, Valentin JP, Fossa AA, Volders PG. Bass A, et al. J Pharmacol Toxicol Methods. 2007 Sep-Oct;56(2):91-4. doi: 10.1016/j.vascn.2007.05.001. Epub 2007 May 24. J Pharmacol Toxicol Methods. 2007. PMID: 17707127

6

Measuring the risk of torsades de pointes: electrocardiographic evaluation of PNU-142093 in conscious cynomolgus non-human primates using restraint and non-restraint procedures.

Bass AS, Hanson LA, Jackson TA. Bass AS, et al. J Pharmacol Toxicol Methods. 2009 Jul-Aug;60(1):51-7. doi: 10.1016/j.vascn.2009.05.003. Epub 2009 May 14. J Pharmacol Toxicol Methods. 2009. PMID: 19447184

7

Origins, practices and future of safety pharmacology.

Bass A, Kinter L, Williams P. Bass A, et al. J Pharmacol Toxicol Methods. 2004 May-Jun;49(3):145-51. doi: 10.1016/j.vascn.2004.02.007. J Pharmacol Toxicol Methods. 2004. PMID: 15172010 Review.

8

Challenges and lessons learned since implementation of the safety pharmacology guidance ICH S7A.

Valentin JP, Bass AS, Atrakchi A, Olejniczak K, Kannosuke F. Valentin JP, et al. Among authors: bass as. J Pharmacol Toxicol Methods. 2005 Jul-Aug;52(1):22-9. doi: 10.1016/j.vascn.2005.04.009. J Pharmacol Toxicol Methods. 2005. PMID: 15961324 Review.

9

Exploratory drug safety: a discovery strategy to reduce attrition in development.

Bass AS, Cartwright ME, Mahon C, Morrison R, Snyder R, McNamara P, Bradley P, Zhou YY, Hunter J. Bass AS, et al. J Pharmacol Toxicol Methods. 2009 Jul-Aug;60(1):69-78. doi: 10.1016/j.vascn.2009.04.194. Epub 2009 May 5. J Pharmacol Toxicol Methods. 2009. PMID: 19422924 Review.

10

ILSI-HESI cardiovascular safety subcommittee initiative: evaluation of three non-clinical models of QT prolongation.

Hanson LA, Bass AS, Gintant G, Mittelstadt S, Rampe D, Thomas K. Hanson LA, et al. Among authors: bass as. J Pharmacol Toxicol Methods. 2006 Sep-Oct;54(2):116-29. doi: 10.1016/j.vascn.2006.05.001. Epub 2006 May 9. J Pharmacol Toxicol Methods. 2006. PMID: 16843688

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,064 results

Search Page

Filters